n n n ‘. concat(e. i18n. t(“search. voice. recognition_retry”),’n
NAIROBI (Reuters) – Germany’s Bayer will hire a third party to distribute its prescription drugs in four African markets in addition to Kenya, it said, adding that the effect on employment would be minimal.
The company, which has 200 workers in the region, said the move targeting Kenya, Ethiopia, Nigeria and Ghana will have no effect on its phytosanitary division, which accounts for 90% of its business.
Bayer will outsource warehousing, distribution and advertising representation of the drug business, including oncology and ophthalmology, to an unnamed third company starting in May, it said.
The company did not say how many jobs would be affected, citing the ongoing process of identifying those jobs.
The move mirrors that of Britain’s GSK, which announced in late 2022 that it would move to a third-party distribution system for its medicines and vaccines in Kenya and close its sales organization in the East African country.
(Reporting by Duncan Miriri; editing by Jason Neely)